Upload Avatar (500 x 500)
Li Qiang Pan
Pharmaceutical Sciences
Zhejiang University
Zhejiang
Language: Chinese, English
Contact
Biotechnology Drugs Tumor Immunotherapy Antibodies Ligands Tcr-Mimic Immune Cells Signal Networks Targeted Therapy
Areas of Focus
  • New Biotechnological Drugs
  • Tumor Immunotherapy
  • Immune Receptor Activation Mechanisms
Work Experience
  • 2022-present - Zhejiang University College of Pharmaceutical Sciences - Assistant to the Dean
  • 2020-2021 - The First Affiliated Hospital, Zhejiang University School of Medicine - Assistant to the Dean
  • 2019-present - Zhejiang University College of Pharmaceutical Sciences - Researcher, Doctoral Supervisor
  • 2015-2018 - Harvard Medical School - Postdoctoral Fellow
  • 2014-2015 - Zhejiang University College of Pharmaceutical Sciences - Postdoctoral Fellow, Assistant Researcher
Awards
  • 2022: Third Prize of Zhejiang Provincial Natural Science Award
  • 2021: MIT Technology Review 'Innovators Under 35 Asia Pacific'
  • 2021: First Prize in Young Teacher Teaching Skills Competition, Zhejiang University College of Pharmaceutical Sciences
  • 2021: Third Prize in Young Teacher Teaching Skills Competition, Zhejiang University
  • 2021: Shihua Yu Young Teacher Award, Zhejiang University
  • 2020: Excellent Newcomer Friend, Zhejiang University
  • 2020: 'Mingde Hongyao' Annual Person of the Year - Outstanding Young Teacher, Zhejiang University College of Pharmaceutical Sciences
  • 2020: 'Kang Enbei Outstanding Young Scientist' First Prize, Zhejiang University College of Pharmaceutical Sciences
  • 2014: Sanofi Young Biopharmaceutical Award, Chinese Pharmaceutical Association
  • 2014: Nomination for Excellent Doctoral Dissertation, Zhejiang University
Post a Project

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.